Second‐line pharmacological treatment strategies for trigeminal neuralgia: A retrospective comparison of lacosamide, gabapentin and baclofen
Lacosamide may be a viable second-line treatment option for refractory trigeminal neuralgia, showing comparable outcomes to gabapentin and baclofen.
Authors
- Mariano Huerta Villanueva (ORCID: https://orcid.org/0000-0003-0181-5335)
- Raquel Tena‐Cucala (ORCID: https://orcid.org/0000-0002-2179-0297)
- Sergio Campoy (ORCID: https://orcid.org/0000-0002-8135-4139)
- Albert Muñoz‐Vendrell (ORCID: https://orcid.org/0000-0001-8221-865X)
- Sergio Martínez‐Yélamos (ORCID: https://orcid.org/0000-0001-9889-2040)
- Paloma Valín‐Villanueva
Institutions
- Bellvitge University Hospital (ES)
- Institut d'Investigació Biomédica de Bellvitge (ES)
- Hospital de Viladecans (ES)
- Hospital Universitari de Tortosa Verge de la Cinta (ES)
- Universitat de Barcelona (ES)
Publication Details
- Journal
- Headache The Journal of Head and Face Pain
- Published
- 2025-05-08
- DOI
- https://doi.org/10.1111/head.14952
- Citations
- 5
- Primary Topic
- Trigeminal Neuralgia and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 7.36